Filing Flows › InspireMD (NSPR) › Q2 2025
InspireMD (NSPR) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 4, 2025
InspireMD (NSPR) reported revenue of $1.8M for the second quarter 2025 (Q2 2025), +2% from a year earlier and +16% from the quarter before. Operating margin was -732.2%, net loss $13.2M (739.7% of revenue).
InspireMD, Q2 2025: revenue $1.8M (+2% year over year), operating margin -732.2%, net loss $13.2M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | +16% | +2% |
| Operating profit | −$13.0M | — | — |
| Net earnings | −$13.2M | — | — |
| Operating cash flow | −$8.3M | — | — |
What changed
Revenue was $1.8M in Q2 2025, up 2% year over year and up 16% from the previous quarter.
Gross margin was 17.6%, down 1.4 points from a year earlier. Operating costs exceeded revenue by $13.0M, an operating margin of -732.2%. Operating expenses grew 55% against revenue growth of 2%. The fastest-growing cost line was Sales & marketing (+189%). The quarter ended with a net loss of $13.2M, wider than the previous quarter's $11.2M loss.
Operating cash flow was −$8.3M. Non-cash charges added back $107K of depreciation and $3.2M of share-based compensation. Working capital and other items added $1.5M. Capital expenditures of $576K exceeded it, leaving free cash flow of −$8.9M.
Questions
What was InspireMD's revenue in the second quarter 2025?
InspireMD (NSPR) reported revenue of $1.8M for the second quarter 2025 (Q2 2025), +2% from a year earlier and +16% from the quarter before.
Was InspireMD profitable in the second quarter 2025?
Operating loss was $13.0M (-732.2% of revenue) and net loss $13.2M.
Source: InspireMD 10-Q on SEC EDGAR.